These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35243027)

  • 1. Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study.
    Baydoun A; Chen H; Poon I; Badellino S; Dagan R; Erler D; Foote MC; Louie AV; Redmond KJ; Ricardi U; Sahgal A; Biswas T
    Clin Transl Radiat Oncol; 2022 Mar; 33():159-164. PubMed ID: 35243027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
    König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution's experience.
    Chai G; Yin Y; Zhou X; Hu Q; Lv B; Li Z; Shi M; Zhao L
    Transl Lung Cancer Res; 2020 Aug; 9(4):1496-1506. PubMed ID: 32953521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis.
    Franzese C; Nicosia L; Facondo G; Lo Faro L; Cuccia F; Vullo G; Osti MF; Alongi F; Scorsetti M
    Clin Exp Metastasis; 2021 Dec; 38(6):511-518. PubMed ID: 34651241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy of adrenal metastases-A dose-finding study.
    Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Sweeney RA; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
    Int J Cancer; 2022 Aug; 151(3):412-421. PubMed ID: 35383919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
    Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
    BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients.
    Arcidiacono F; Aristei C; Marchionni A; Italiani M; Fulcheri CPL; Saldi S; Casale M; Ingrosso G; Anselmo P; Maranzano E
    Br J Radiol; 2020 Nov; 93(1115):20200645. PubMed ID: 32822540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer.
    Sheikh S; Chen H; Sahgal A; Poon I; Erler D; Badellino S; Dagan R; Foote MC; Louie AV; Redmond KJ; Ricardi U; Biswas T
    Radiother Oncol; 2022 Feb; 167():187-194. PubMed ID: 34952002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
    Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
    BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Radiotherapy for Adrenal Metastases: A Multi-Institutional Review of Patient Characteristics and Outcomes - Turkish Society for Radiation Oncology SBRT Group Study (Trod SBRT 10-004).
    Elmali A; Akkus Yildirim B; Cengiz M; Yuce Sari S; Onal HC; Berber T; Arslantas Erken A; Zoto Mustafayev T; Atalar B; Unal I; Kaydihan N; Oner Dincbas F
    Oncol Res Treat; 2022; 45(12):717-727. PubMed ID: 36116432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: a bi-institutional analysis.
    Ehret F; Kaul D; Kufeld M; Endt CV; Budach V; Senger C; Fürweger C; Haidenberger A; Muacevic A
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1095-1101. PubMed ID: 35290521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study.
    Facondo G; Vullo G; Valeriani M; Ascolese AM; De Sanctis V; Osti MF
    Cancer Treat Res Commun; 2021; 29():100481. PubMed ID: 34700142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results.
    Michalet M; Bettaïeb O; Khalfi S; Ghorbel A; Valdenaire S; Debuire P; Aillères N; Draghici R; De Méric De Bellefon M; Charissoux M; Boisselier P; Demontoy S; Marguerit A; Cabaillé M; Cantaloube M; Keskes A; Bouhafa T; Farcy-Jacquet MP; Fenoglietto P; Azria D; Riou O
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.
    Yeung R; Hamm J; Liu M; Schellenberg D
    Radiat Oncol; 2017 Jun; 12(1):105. PubMed ID: 28637480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy (SBRT) of adrenal gland metastases in oligometastatic and oligoprogressive disease.
    Reshko LB; Gaskins JT; Silverman CL; Dunlap NE
    Rep Pract Oncol Radiother; 2021; 26(3):325-340. PubMed ID: 34277086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
    Wang X; Zamdborg L; Ye H; Grills IS; Yan D
    BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
    Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
    Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
    Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
    Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases.
    Cao Y; Chen H; Sahgal A; Erler D; Badellino S; Biswas T; Dagan R; Foote MC; Louie AV; Poon I; Ricardi U; Redmond KJ
    Radiother Oncol; 2021 Nov; 164():98-103. PubMed ID: 34454974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
    Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
    Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.